Holocene Advisors, LP Biogen Inc. Transaction History

Holocene Advisors, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $52.4 Million - $60.5 Million	-190,314 Reduced 98.05%	3,791 $1.08 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $49.8 Million - $56.7 Million	194,105 New	194,105 $54 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $387,696 - $505,598	-1,370 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $58.6 Million - $93.8 Million	-226,099 Reduced 99.4%	1,370 $474,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $6.04 Million - $7.66 Million	-22,473 Reduced 8.99%	227,469 $72 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $55 Million - $76 Million	249,942 New	249,942 $74.2 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $238,463 - $284,198	-926 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $240,880 - $340,684	926 New	926 $254,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.